(Q58010138)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882045%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

title

Impact of adjunct cytogenetic abnormalities for prognostic stratification in patients with myelodysplastic syndrome and deletion 5q (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882045%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1 reference

myelodysplastic syndrome

1 reference

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882045%20AND%20SRC:MED&resulttype=core&format=json

Jesus Maria Hernandez Rivas

14 February 2020

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882045%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

M J Calasanz

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882045%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Peter Valent

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882045%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Leonor Arenillas

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882045%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Lourdes Florensa

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882045%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

author name string

M Mallo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882045%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

J Cervera

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882045%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

J Schanz

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882045%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

E Such

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882045%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

G García-Manero

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882045%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

E Luño

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882045%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

C Steidl

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882045%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

B Espinet

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882045%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

T Vallespí

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882045%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

U Germing

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882045%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

K Ohyashiki

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882045%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

J Grau

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882045%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

M Pfeilstöcker

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882045%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

T Noesslinger

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882045%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

A Giagounidis

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882045%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

C Aul

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882045%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

M L Martín

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882045%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

R Collado

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882045%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

C Fonatsch

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882045%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

M Lübbert

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882045%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

R Stauder

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882045%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

B Hildebrandt

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882045%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

O Krieger

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882045%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

C Pedro

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882045%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

M Á Sanz

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882045%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

A Valencia

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882045%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

G F Sanz

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882045%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

D Haase

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882045%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

F Solé

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882045%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

C Haferlach

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882045%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

publication date

30 September 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882045%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882045%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882045%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882045%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

page(s)

110-120

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882045%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/leu.2010.231

14 February 2020

exact match

0 references

cites work

Proposals for the classification of the myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.231

World Health Organization classification in combination with cytogenetic markers improves the prognostic stratification of patients with de novo primary myelodysplastic syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.231

Cytogenetic abnormalities in a series of 1,029 patients with primary myelodysplastic syndromes: a report from the US with a focus on some undefined single chromosomal abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.231

Clinical, morphological, cytogenetic, and prognostic features of patients with myelodysplastic syndromes and del(5q) including band q31

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.231

Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.231

Efficacy of lenalidomide in myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.231

Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.231

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.231

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.231

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.231

Cytogenetic features in myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.231

Clinical relevance of cytogenetics in myelodysplastic syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.231

Deletion 5q in myelodysplastic syndrome: a paradigm for the study of hemizygous deletions in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.231

WHO-defined 'myelodysplastic syndrome with isolated del(5q)' in 88 consecutive patients: survival data, leukemic transformation rates and prevalence of JAK2, MPL and IDH mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.231

Recurrent IDH mutations in high-risk myelodysplastic syndrome or acute myeloid leukemia with isolated del(5q).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.231

New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.231

7 January 2021

Implementation of standardized international karyotype scoring practices is needed to provide uniform and systematic evaluation for patients with myelodysplastic syndrome using IPSS criteria: An International Working Group on MDS Cytogenetics Study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.231

7 January 2021

Efficacy of conventional cytogenetics and FISH for EGR1 to detect deletion 5q in hematological disorders and to assess response to treatment with Lenalidomide

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.231

7 January 2021

Outcome following haematopoietic cell transplantation in patients with myelodysplasia and del (5q) karyotypes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.231

7 January 2021

Myelodysplastic syndromes associated with interstitial deletion of chromosome 5q: clinicopathologic correlations and new insights from the pre-lenalidomide era

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.231

7 January 2021

Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.231

7 January 2021